DarioHealth launches strategic review, raises $17.5M via private placement

DarioHealth Corp.

Board formed Special Committee, engaged Perella Weinberg as advisor to explore sale, merger, or standalone.
Raised $17.5M gross via private placement of 1.15M shares and 1.56M pre-funded warrants at $6.45/share.
Series C-1 Preferred mandatory conversion accelerated; holders receive common stock or pre-funded warrants plus dividends.
Offering closed September 23, 2025; net proceeds for general corporate purposes.
Strategic review follows multiple unsolicited inbound inquiries from interested parties.

item 1.01item 3.02item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.